000 01455 a2200385 4500
005 20250514224034.0
264 0 _c20050823
008 200508s 0 0 eng d
022 _a1535-6108
024 7 _a10.1016/j.ccr.2005.04.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSebti, Saïd M
245 0 0 _aProtein farnesylation: implications for normal physiology, malignant transformation, and cancer therapy.
_h[electronic resource]
260 _bCancer cell
_cApr 2005
300 _a297-300 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlkyl and Aryl Transferases
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aCaenorhabditis elegans
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Transformation, Neoplastic
_xmetabolism
650 0 4 _aEmbryonic Development
_xphysiology
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHomeostasis
_xphysiology
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Prenylation
_xdrug effects
650 0 4 _aProtein Processing, Post-Translational
_xphysiology
650 0 4 _arab GTP-Binding Proteins
_xmetabolism
650 0 4 _aras Proteins
_xmetabolism
650 0 4 _arho GTP-Binding Proteins
_xmetabolism
773 0 _tCancer cell
_gvol. 7
_gno. 4
_gp. 297-300
856 4 0 _uhttps://doi.org/10.1016/j.ccr.2005.04.005
_zAvailable from publisher's website
999 _c15505858
_d15505858